Why has the number of abortions in the United States stayed remarkably steady—even as a wave of state bans and restrictions have swept the country since 2022? This question has left both policymakers and the public searching for answers, particularly as new data shows that for two consecutive years, the national abortion count has hovered around 1.1 million. The story behind these numbers reveals a rapidly shifting landscape of access, technology, and legal maneuvering, painting a complex portrait of American reproductive health in the post-Roe era.
Short answer: Despite the dramatic increase in state abortion bans and restrictions, the overall number of abortions in the U.S. has remained stable—about 1,126,000 in both 2024 and 2025—because people are increasingly accessing abortions via telemedicine and mail-order medication, often shielded by protective state laws. These new methods have reduced the need for travel and circumvented many state-level restrictions, fundamentally changing how and where abortions occur without reducing their total number.
The Numbers: A Surprising Plateau
Let’s start with the data itself. According to the Guttmacher Institute, a leading reproductive health research organization, “there were an estimated 1,126,000 abortions provided by clinicians in the U.S. in 2025—that’s pretty much unchanged from 2024” (as reported by knpr.org and confirmed by tag24.com and houstonpublicmedia.org). This stability persists even after the Supreme Court overturned Roe v. Wade in 2022, which triggered a cascade of new state-level bans and restrictions. By 2025, 13 states had total abortion bans, and another six had bans at six or twelve weeks into pregnancy (tag24.com). Yet, despite what many expected to be a sharp decline, “the number of abortions across the US has remained stable.”
How is this possible? The answer lies in adaptation—both technological and legal—by those seeking, providing, and supporting abortion access.
Telemedicine and Medication: The New Frontier
One of the most transformative changes since the fall of Roe is the rise of telemedicine abortions. In 2023, the Food and Drug Administration made a pivotal policy shift by allowing mifepristone—one of the two main medications used for medical abortion—to be prescribed without requiring an in-person doctor’s visit (wqcs.org, houstonpublicmedia.org). This meant that patients could consult with healthcare providers remotely and receive abortion pills by mail, even if they lived in states where in-person abortion services were banned.
This change has been a game-changer. “A key way that abortions are now happening despite all of the state restrictions is through telemedicine,” explains Isaac Maddow-Zimet, a Guttmacher Institute data scientist, in coverage by both opb.org and knpr.org. Shield laws passed by abortion-supportive states have further protected providers who prescribe and mail these medications to patients in states with bans, reducing their legal risk (tag24.com, ijpr.org).
The impact is clear in the numbers: In 2025, an estimated 91,000 patients in states with abortion bans received telehealth abortions—a dramatic rise compared to previous years (houstonpublicmedia.org, wvasfm.org). This shift means that rather than traveling long distances to states where abortion remains legal, more people can access care discreetly from their own homes.
Changing Patterns: Less Travel, More At-Home Care
Before these telemedicine options were widely available, people in restrictive states often had to travel across state lines to obtain an abortion. The new ease of access through the mail has changed this dynamic. The Guttmacher report, cited by tag24.com, notes that “more people in states with restrictions used telemedicine to get abortions, and fewer traveled out of state.” As Maddow-Zimet told NPR, “It makes sense that we’d see a decline in travel because people accessing abortion care through telehealth in general then no longer need to travel for care.”
A personal story from “Viv,” a 27-year-old in Atlanta, illustrates this new reality. Unable to get an in-person abortion in Georgia due to the state’s six-week ban, she turned to the internet, found a provider in Massachusetts, and received abortion pills by mail—never having to leave home or take time off work (wqcs.org, opb.org). Her experience is increasingly typical, as thousands of others use similar channels.
Legal Battles and Political Frustrations
While telemedicine and shield laws have opened new avenues for abortion access, these innovations have also sparked fierce opposition. Anti-abortion advocates have filed lawsuits and pushed for federal legislation to block the mailing of mifepristone, arguing that it undermines state bans and endangers patients (wqcs.org, tag24.com). In January 2026, Louisiana Attorney General Liz Murrill told a U.S. Senate committee that “Louisiana’s efforts to protect mothers and their unborn children and to hold out-of-state abortion pill traffickers accountable for the harm they inflict will be all but futile” as long as the FDA allows these pills to be mailed (houstonpublicmedia.org).
Despite these challenges, legal protections in supportive states remain robust. Shield laws are designed to insulate providers from out-of-state prosecution, complicating enforcement efforts by states with bans (tag24.com, ijpr.org). Misoprostol, the second medication commonly used for abortion, is even harder to restrict, as it is also widely prescribed for other medical conditions.
Regional Shifts: How and Where Abortions Happen
Perhaps the most significant change is not in the number of abortions but in their geographic and procedural distribution. As tag24.com notes, “the number of abortions hasn't changed, but the where and how have.” States with strict bans have seen in-person abortion numbers drop, but these declines are offset by increases in telehealth and out-of-state care. For example, in Louisiana, the number of abortions reportedly rose from about 2,500 in 2023 to more than 9,000 the following year, much of it attributed to telehealth access (knpr.org, houstonpublicmedia.org).
This shifting landscape also means that abortion providers and support networks are adapting rapidly. Organizations like The MAP in Massachusetts facilitate online consultations, sliding-scale fees, and follow-up care—making the process more accessible and safer for those in restrictive states (wqcs.org, opb.org).
The Broader Context: Health and Autonomy
The persistence of abortion numbers despite legal barriers also reflects broader social and health realities. As Viv points out, Georgia has “one of the highest maternal mortality rates in the country,” underscoring the stakes for women seeking reproductive autonomy (wqcs.org). The availability of safe, effective abortion pills—mifepristone and misoprostol—provides a critical option for those who cannot or do not want to carry a pregnancy to term, especially in states with poor maternal health outcomes.
Uncertainties Ahead: Legal and Policy Fights Continue
The current equilibrium is not guaranteed to last. Legal challenges continue, with a key federal court case—Louisiana v. FDA—expected to rule soon on whether the FDA’s mail-order policy for mifepristone will stand (houstonpublicmedia.org, ijpr.org). Congressional efforts to restrict telemedicine abortions are also ongoing, and any change in federal policy could have a significant impact on access.
Nevertheless, the data from 2024 and 2025 show that, so far, “those efforts haven’t worked in one basic way: the number of abortions in the country hasn’t budged” (opb.org). The ingenuity of telemedicine, the rise of shield laws, and the persistently high demand for abortion services have all combined to keep the overall figures steady, even as the routes to access have changed dramatically.
Conclusion: Adaptation Outpaces Restriction
In sum, the reason the number of abortions in the U.S. has remained steady—despite a patchwork of new bans and restrictions—is that access has shifted from clinics and interstate travel to telemedicine and mail-order medication, protected by shield laws in supportive states. The experience of patients like Viv, the legal innovations by providers, and the resilience of support networks have all contributed to this new status quo. As the Guttmacher Institute and multiple media outlets such as knpr.org, tag24.com, houstonpublicmedia.org, and opb.org report, the story of abortion in America today is not one of fewer procedures, but of new pathways and persistent demand—“the number of abortions hasn't changed, but the where and how have” (tag24.com). The coming years will test how durable these new forms of access remain in the face of ongoing legal and political battles.